Regulation of the Immune Checkpoint Indoleamine 2,3-Dioxygenase Expression by Epstein–Barr Virus

Regulation of the Immune Checkpoint Indoleamine 2,3-Dioxygenase Expression by Epstein–Barr Virus

Epstein–Barr virus (EBV) is an oncovirus ubiquitously distributed and associated with different types of cancer. The reason why only a group of infected people develop cancer is still unknown. EBV-associated cancers represent about 1.8% of all cancer deaths worldwide, with more than 150,000 new case...

Full description

Bibliographic Details
Main Authors:	Leila Sawada, Antonio Carlos Rosário Vallinoto, Igor Brasil-Costa
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Biomolecules
Subjects:	Epstein–Barr virus immune checkpoints indoleamine 2,3-dioxygenase
Online Access:	https://www.mdpi.com/2218-273X/11/12/1792

Similar Items

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
by: Chiara Suvieri, et al.
Published: (2024-11-01)

Research progress of indoleamine 2,3-dioxygenase 1 in gastric cancer
by: Pei Xiaxia, et al.
Published: (2023-03-01)

Increased Indoleamine 2,3-Dioxygenase 1 (IDO-1) Activity and Inflammatory Responses during Chikungunya Virus Infection
by: Thiara Manuele Alves de Souza, et al.
Published: (2022-04-01)

Association of Indoleamine 2,3-Dioxygenase (IDO) Activity with Outcome after Cardiac Surgery in Adult Patients
by: Andrea Stieger, et al.
Published: (2024-06-01)

Significance of Indoleamine 2,3-Dioxygenase Expression in the Immunological Response of Kidney Graft Recipients
by: Krzysztof Wiśnicki, et al.
Published: (2022-09-01)

Indoleamine 2,3-dioxygenase 1 inhibitor Epacadostat combined with IFN-γ induces apoptosis of triple-negative breast cancer cell lines
by: HU Qing-qing, LU Yan
Published: (2020-05-01)

The Role of Indoleamine 2,3-Dioxygenase in Renal Tubular Epithelial Cells Senescence under Anoxia or Reoxygenation
by: Theodoros Eleftheriadis, et al.
Published: (2021-10-01)

Immunohistochemical Detection of Indoleamine 2,3-Dioxygenase in Spontaneous Mammary Carcinomas of 96 Pet Rabbits
by: Sandra Schöniger, et al.
Published: (2024-07-01)

Interleukin‐6 promotes skeletal muscle catabolism by activating tryptophan–indoleamine 2,3‐dioxygenase 1–kynurenine pathway during intra‐abdominal sepsis
by: Tingbin Xie, et al.
Published: (2023-04-01)

Inhibitory effect of human indoleamine 2,3-dioxygenase 1 (hIDO1) by kazinols of 1,3-diphenylpropane derivatives
by: Taehoon Oh, et al.
Published: (2024-09-01)

Improving the Anti-Tumor Effect of Indoleamine 2,3-Dioxygenase Inhibitor CY1-4 by CY1-4 Nano-Skeleton Drug Delivery System
by: Hui Li, et al.
Published: (2024-12-01)

Tryptophan deficiency induced by indoleamine 2,3‐dioxygenase 1 results in glucose transporter 1‐dependent promotion of aerobic glycolysis in pancreatic cancer
by: Heng Liang, et al.
Published: (2024-05-01)

Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells
by: Marta Cecchi, et al.
Published: (2021-03-01)

Structure–activity relationship studies of 5-(Pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 inhibitors
by: Jiawei Zhang, et al.
Published: (2024-01-01)

Epstein-Barr virus-related lymphoproliferative disorders of the skin
by: Gerardo Ferrara, et al.
Published: (2024-05-01)

Effect of Physical Activity on the Gene Expression of Indoleamine 2, 3-dioxygenase 1 and Arylalkylamine N-acetyltransferase in the Cerebellum of Female Mice with Experimental Autoimmune Encephalomyelitis
by: samira emadi, et al.
Published: (2024-05-01)

Effect of Exogenous of Transforming Growth Factor-β1 on Pregnancy Outcome in Mice with Recurrent Pregnancy Loss by Persistent Enhancement of Placental Tissue Indoleamine 2,3-Dioxygenase Expression
by: Xinghui Wen, et al.
Published: (2025-01-01)

Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders
by: Adrian Mor, et al.
Published: (2024-07-01)

Epstein-Barr Virus Neurologic Complications
by: J. Gordon Millichap
Published: (2015-12-01)

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
by: Alison Felipe Bordini Biggi, et al.
Published: (2022-03-01)

Clinical significance of anti-Epstein–Barr virus antibodies in systemic chronic active Epstein–Barr virus disease
by: Miwako Nishio, et al.
Published: (2024-01-01)

Hydrophobic ion pairing and microfluidic nanoprecipitation enable efficient nanoformulation of a small molecule indolamine 2, 3‐dioxygenase inhibitor immunotherapeutic
by: Parisa Badiee, et al.
Published: (2024-01-01)

Epstein–Barr Virus Infection in Lung Cancer: Insights and Perspectives
by: Julio C. Osorio, et al.
Published: (2022-01-01)

Role of rapidly evolving immunotherapy in chronic active Epstein-Barr virus disease
by: Sijia Yan, et al.
Published: (2024-12-01)

Epstein-Barr Virus Infection in Children: Improving the Diagnosis and Treatment Program
by: E. N. Simovanyan, et al.
Published: (2016-04-01)

Infectious mononucleosis by Epstein-Barr virus: A complete laboratory picture
by: Marco P.Barros Pinto
Published: (2024-04-01)

CHRONIC INFLAMMATION OF THE TONSILS ASSOCIATED WITH EPSTEIN-BARR VIRUS
by: L A Baryshevskaya, et al.
Published: (2018-03-01)

Molecular detection of Epstein Barr Virus in Women with Breast cancer
by: Areej A. Hussein
Published: (2013-07-01)

Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
by: Ruyue Chen, et al.
Published: (2023-09-01)

Lipopolysaccharide-Induced Immunological Tolerance in Monocyte-Derived Dendritic Cells
by: Jacques C. Mbongue, et al.
Published: (2022-08-01)

Dysfunction of γδ T cells in pediatric chronic active Epstein-Barr virus infection
by: Junhong Ai, et al.
Published: (2024-10-01)

Epstein–Barr Virus Association with Breast Cancer: Evidence and Perspectives
by: Claudia Arias-Calvachi, et al.
Published: (2022-05-01)

EPSTEIN-BARR VIRUS AND LYMPHOMA IN RHEUMATOID ARTHRITIS: PREVALENCE AND ASSOCIATION WITH METHOTREXATE. RESULT OF SYSTEMATIC REVIEW OF OBSERVATIONAL STUDIES
by: Camila Frade OLIVEIRA, et al.
Published: (2024-04-01)

EPSTEIN-BARR VIRUS: CAUSES, CONSEQUENCES, DIAGNOSIS AND TREATMENT OF EPSTEIN-BARR VIRUS IN HUMAN
by: Koprivica Marko
Published: (2024-04-01)

Plasma Epstein-Barr Virus DNA load for diagnostic and prognostic assessment in intestinal Epstein-Barr Virus infection
by: Chunxiang Ma, et al.
Published: (2025-01-01)

IFNγ-INDUCED KINURENINE PRODUCTION AND INDOLAMINE 2,3-DIOXYGENASE GENE EXPRESSION IN PSORIASIS
by: D. A. Kaut, et al.
Published: (2014-07-01)

GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor
by: Chenlu Huang, et al.
Published: (2024-09-01)

Epstein-Barr Virus and Opsoclonus Myoclonus Syndrome
by: J Gordon Millichap
Published: (2002-04-01)

Tumor Microenvironment‐Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression
by: Mengna Wang, et al.
Published: (2025-02-01)